In patients with type 1 diabetes, do insulin pumps improve outcomes compared with self-injections?
Metadata[+] Show full item record
Continuous subcutaneous insulin infusion (CSII) is equal to or better than multiple daily injections (MDI) for decreasing HbA1c in patients with type 1 diabetes. (SOR: C, disease-oriented evidence from multiple systematic reviews.) The difference in relative frequency of clinically significant hypoglycemic events between the 2 treatments is unclear.
Evidence Based Practice 15(5): 07.